We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
NRG-GY018研究分析：帕博利珠单抗联合化疗改善子宫内膜癌生存率。dMMR患者死亡风险降低44%。详情见ASCO 2026。
